Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

Find My GLP-1 Path
Kaden Coziar

Kaden Coziar

Founder & Managing Editor, The RX Index

Research editor — not a physician or medical provider

Kaden Coziar is the founder and managing editor of The RX Index. He edits and takes responsibility for The RX Index Research, the site's independent collection of trackers, datasets, and policy reviews on GLP-1 medications.

Research areas

  • GLP-1 access and prescribing channels
  • Prescription-drug pricing and payment programs
  • Insurance coverage, including Medicaid, Medicare, employer, and ACA Marketplace plans
  • FDA regulatory policy, compounding rules, and enforcement records
  • Patents, generic entry, shortages, and prescription-drug market data

Role and responsibility

Kaden is the named author of every research asset listed below. For each one he is responsible for source selection, verification against primary records, dated releases, the methodology notes, and corrections. Research pages state when each finding was last verified and what the evidence does and does not establish.

Kaden is an editor and researcher. He is not a physician, pharmacist, or other licensed healthcare provider, and his work is not medical advice. When a page has been reviewed by a clinician, it names that medical reviewer, their credentials, and the review date separately from the author byline, as described in the medical review policy.

Consumer guides, comparisons, and provider reviews elsewhere on the site are published under the RX Index Editorial Team byline.

How the research is produced

  • Findings are drawn from primary sources where available: state Medicaid and plan documents, CMS and FDA records, court dockets, manufacturer filings, and peer-reviewed trials.
  • Secondary analyses (for example KFF or industry surveys) are labeled as such and dated.
  • Material changes are released as dated versions. Where a dataset is published, it comes with downloadable files and citation formats.
  • Methods are documented in the research methodology, and revisions are logged in the research changelog.

Financial interest disclosure

As founder, Kaden has a financial interest in The RX Index. The site earns affiliate commissions from some links in its consumer guides; see the affiliate disclosure. Research pages carry no affiliate links. Where they link to a related consumer guide, that link is labeled and kept separate from the findings.

Citing and contacting

Suggested citation format for research assets:

Coziar, Kaden. “[Title].” The RX Index Research. [Release or update date]. [URL].

Journalists, researchers, and readers can reach Kaden at hello@therxindex.com. To report an error, see the corrections policy.

Research by Kaden Coziar (29)

Coverage & access

Pricing & market data

Medicare & public programs

Regulation & enforcement

Patents, generics & supply

Clinical evidence & safety data